Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment
Purpose To update the oncologic outcomes and safety for microwave (MW) ablation of T1a (≤4.0 cm) and T1b (4.1–7.0 cm) renal cell carcinoma (RCC) with emphasis on tumor complexity and single session treatment. Materials and Methods Retrospective review of 29 consecutive patients (30 tumors) with loca...
Gespeichert in:
| Veröffentlicht in: | Abdominal imaging 2016-06, Vol.41 (6), p.1203-1211 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1211 |
|---|---|
| container_issue | 6 |
| container_start_page | 1203 |
| container_title | Abdominal imaging |
| container_volume | 41 |
| creator | Wells, Shane A. Wheeler, Karen M. Mithqal, Ayman Patel, Mehul S. Brace, Christopher L. Schenkman, Noah S. |
| description | Purpose
To update the oncologic outcomes and safety for microwave (MW) ablation of T1a (≤4.0 cm) and T1b (4.1–7.0 cm) renal cell carcinoma (RCC) with emphasis on tumor complexity and single session treatment.
Materials and Methods
Retrospective review of 29 consecutive patients (30 tumors) with localized (NOMO) RCC (23 T1a; 7 T1b) treated with percutaneous MW ablation between 3/2013 and 6/2014. Primary outcomes investigated were technical success, local tumor progression (LTP), and complications. Technical success was assessed with contrast-enhanced computed tomography (CECT) immediately after MW ablation. Presence of LTP was assessed with CECT or contrast-enhanced magnetic resonance at 6-month target intervals for the first two years and annually thereafter. Complications were categorized using the Clavien-Dindo classification system.
Results
Median tumor diameter was 2.8 cm [IQR 2.1–3.3] for T1a and 4.7 cm [IQR 4.1–5.7] for T1b tumors. Median RENAL nephrometry score was 7 [IQR 4–8] for T1a tumors and 9 [IQR 6.25–9.75] for T1b tumors. Technical success was achieved for 22 T1a (96%) and 7 T1b (100%) tumors. There were no LTP during a median imaging follow-up of 12.0 months [IQR 6–18] for the 23 patients (24 tumors) with greater than 6 months of follow-up. There were three Clavien-Dindo grade I–II complication (10%) and no Clavien-Dindo grade III–V complications (0%). All but two patients (93%) are alive without metastatic disease; two patients died after 12-month follow-up of causes unrelated to the MW ablation.
Conclusion
Percutaneous MW ablation appears to be a safe and effective treatment option for low, moderate, and highly complex T1a and T1b RCC in early follow-up. |
| doi_str_mv | 10.1007/s00261-016-0776-x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1793905372</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4227644981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-9b79a3bed466c67d38a0ca892f12403943c5791329e51196396609e6ca762add3</originalsourceid><addsrcrecordid>eNp1kU1rFTEUhoMotlz7A9xIwI2b0XzcSW7cSfELCrqo4C6cyZzpTZlMrkmmvf1J_kszTi0iuMnJIc95D3lfQp5z9pozpt9kxoTiDeOqYVqr5viInAqpasfa3eOH-_b7CTnL-ZqxSraci_YpORGaKy0kOyU_v2Jyc4EJ45xp8C7FW7hBCt0IxceJxoFecqAw9bV2NOEEI3U41gOS81MM8JbmfUylKZgCxWHwDtzd7wkXw2Gs7aKU6a0ve4rhsIfsM63aZQ4xrRAefVlnsp-uRqQZc172l4RQAk7lGXkywJjx7L5uyLcP7y_PPzUXXz5-Pn930TipRWlMpw3IDvutUk7pXu6AOdgZMXCxZdJspWu14VIYrG4YJY1SzKByoJWAvpcb8mrVPaT4Y8ZcbPB5-fDqkeXaSMPauqyiL_9Br-OcqkGV2kkhuOK1bghfqeptzgkHe0g-QLqznNklSrtGaWtAdonSHuvMi3vluQvYP0z8Ca4CYgVyfZquMP21-r-qvwBChau3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1832216118</pqid></control><display><type>article</type><title>Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Wells, Shane A. ; Wheeler, Karen M. ; Mithqal, Ayman ; Patel, Mehul S. ; Brace, Christopher L. ; Schenkman, Noah S.</creator><creatorcontrib>Wells, Shane A. ; Wheeler, Karen M. ; Mithqal, Ayman ; Patel, Mehul S. ; Brace, Christopher L. ; Schenkman, Noah S.</creatorcontrib><description>Purpose
To update the oncologic outcomes and safety for microwave (MW) ablation of T1a (≤4.0 cm) and T1b (4.1–7.0 cm) renal cell carcinoma (RCC) with emphasis on tumor complexity and single session treatment.
Materials and Methods
Retrospective review of 29 consecutive patients (30 tumors) with localized (NOMO) RCC (23 T1a; 7 T1b) treated with percutaneous MW ablation between 3/2013 and 6/2014. Primary outcomes investigated were technical success, local tumor progression (LTP), and complications. Technical success was assessed with contrast-enhanced computed tomography (CECT) immediately after MW ablation. Presence of LTP was assessed with CECT or contrast-enhanced magnetic resonance at 6-month target intervals for the first two years and annually thereafter. Complications were categorized using the Clavien-Dindo classification system.
Results
Median tumor diameter was 2.8 cm [IQR 2.1–3.3] for T1a and 4.7 cm [IQR 4.1–5.7] for T1b tumors. Median RENAL nephrometry score was 7 [IQR 4–8] for T1a tumors and 9 [IQR 6.25–9.75] for T1b tumors. Technical success was achieved for 22 T1a (96%) and 7 T1b (100%) tumors. There were no LTP during a median imaging follow-up of 12.0 months [IQR 6–18] for the 23 patients (24 tumors) with greater than 6 months of follow-up. There were three Clavien-Dindo grade I–II complication (10%) and no Clavien-Dindo grade III–V complications (0%). All but two patients (93%) are alive without metastatic disease; two patients died after 12-month follow-up of causes unrelated to the MW ablation.
Conclusion
Percutaneous MW ablation appears to be a safe and effective treatment option for low, moderate, and highly complex T1a and T1b RCC in early follow-up.</description><identifier>ISSN: 2366-004X</identifier><identifier>EISSN: 2366-0058</identifier><identifier>DOI: 10.1007/s00261-016-0776-x</identifier><identifier>PMID: 27167230</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Aged ; Biopsy ; Carcinoma, Renal Cell - diagnostic imaging ; Carcinoma, Renal Cell - surgery ; Catheter Ablation - methods ; Contrast Media ; Disease Progression ; Female ; Gastroenterology ; Hepatology ; Humans ; Imaging ; Kidney Neoplasms - diagnostic imaging ; Kidney Neoplasms - surgery ; Magnetic Resonance Imaging ; Male ; Medicine ; Medicine & Public Health ; Microwaves - therapeutic use ; Postoperative Complications - diagnostic imaging ; Radiology ; Retrospective Studies ; Tomography, X-Ray Computed ; Treatment Outcome</subject><ispartof>Abdominal imaging, 2016-06, Vol.41 (6), p.1203-1211</ispartof><rights>Springer Science+Business Media New York 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-9b79a3bed466c67d38a0ca892f12403943c5791329e51196396609e6ca762add3</citedby><cites>FETCH-LOGICAL-c372t-9b79a3bed466c67d38a0ca892f12403943c5791329e51196396609e6ca762add3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00261-016-0776-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00261-016-0776-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27167230$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wells, Shane A.</creatorcontrib><creatorcontrib>Wheeler, Karen M.</creatorcontrib><creatorcontrib>Mithqal, Ayman</creatorcontrib><creatorcontrib>Patel, Mehul S.</creatorcontrib><creatorcontrib>Brace, Christopher L.</creatorcontrib><creatorcontrib>Schenkman, Noah S.</creatorcontrib><title>Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment</title><title>Abdominal imaging</title><addtitle>Abdom Radiol</addtitle><addtitle>Abdom Radiol (NY)</addtitle><description>Purpose
To update the oncologic outcomes and safety for microwave (MW) ablation of T1a (≤4.0 cm) and T1b (4.1–7.0 cm) renal cell carcinoma (RCC) with emphasis on tumor complexity and single session treatment.
Materials and Methods
Retrospective review of 29 consecutive patients (30 tumors) with localized (NOMO) RCC (23 T1a; 7 T1b) treated with percutaneous MW ablation between 3/2013 and 6/2014. Primary outcomes investigated were technical success, local tumor progression (LTP), and complications. Technical success was assessed with contrast-enhanced computed tomography (CECT) immediately after MW ablation. Presence of LTP was assessed with CECT or contrast-enhanced magnetic resonance at 6-month target intervals for the first two years and annually thereafter. Complications were categorized using the Clavien-Dindo classification system.
Results
Median tumor diameter was 2.8 cm [IQR 2.1–3.3] for T1a and 4.7 cm [IQR 4.1–5.7] for T1b tumors. Median RENAL nephrometry score was 7 [IQR 4–8] for T1a tumors and 9 [IQR 6.25–9.75] for T1b tumors. Technical success was achieved for 22 T1a (96%) and 7 T1b (100%) tumors. There were no LTP during a median imaging follow-up of 12.0 months [IQR 6–18] for the 23 patients (24 tumors) with greater than 6 months of follow-up. There were three Clavien-Dindo grade I–II complication (10%) and no Clavien-Dindo grade III–V complications (0%). All but two patients (93%) are alive without metastatic disease; two patients died after 12-month follow-up of causes unrelated to the MW ablation.
Conclusion
Percutaneous MW ablation appears to be a safe and effective treatment option for low, moderate, and highly complex T1a and T1b RCC in early follow-up.</description><subject>Aged</subject><subject>Biopsy</subject><subject>Carcinoma, Renal Cell - diagnostic imaging</subject><subject>Carcinoma, Renal Cell - surgery</subject><subject>Catheter Ablation - methods</subject><subject>Contrast Media</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Imaging</subject><subject>Kidney Neoplasms - diagnostic imaging</subject><subject>Kidney Neoplasms - surgery</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Microwaves - therapeutic use</subject><subject>Postoperative Complications - diagnostic imaging</subject><subject>Radiology</subject><subject>Retrospective Studies</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><issn>2366-004X</issn><issn>2366-0058</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU1rFTEUhoMotlz7A9xIwI2b0XzcSW7cSfELCrqo4C6cyZzpTZlMrkmmvf1J_kszTi0iuMnJIc95D3lfQp5z9pozpt9kxoTiDeOqYVqr5viInAqpasfa3eOH-_b7CTnL-ZqxSraci_YpORGaKy0kOyU_v2Jyc4EJ45xp8C7FW7hBCt0IxceJxoFecqAw9bV2NOEEI3U41gOS81MM8JbmfUylKZgCxWHwDtzd7wkXw2Gs7aKU6a0ve4rhsIfsM63aZQ4xrRAefVlnsp-uRqQZc172l4RQAk7lGXkywJjx7L5uyLcP7y_PPzUXXz5-Pn930TipRWlMpw3IDvutUk7pXu6AOdgZMXCxZdJspWu14VIYrG4YJY1SzKByoJWAvpcb8mrVPaT4Y8ZcbPB5-fDqkeXaSMPauqyiL_9Br-OcqkGV2kkhuOK1bghfqeptzgkHe0g-QLqznNklSrtGaWtAdonSHuvMi3vluQvYP0z8Ca4CYgVyfZquMP21-r-qvwBChau3</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Wells, Shane A.</creator><creator>Wheeler, Karen M.</creator><creator>Mithqal, Ayman</creator><creator>Patel, Mehul S.</creator><creator>Brace, Christopher L.</creator><creator>Schenkman, Noah S.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20160601</creationdate><title>Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment</title><author>Wells, Shane A. ; Wheeler, Karen M. ; Mithqal, Ayman ; Patel, Mehul S. ; Brace, Christopher L. ; Schenkman, Noah S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-9b79a3bed466c67d38a0ca892f12403943c5791329e51196396609e6ca762add3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Biopsy</topic><topic>Carcinoma, Renal Cell - diagnostic imaging</topic><topic>Carcinoma, Renal Cell - surgery</topic><topic>Catheter Ablation - methods</topic><topic>Contrast Media</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Imaging</topic><topic>Kidney Neoplasms - diagnostic imaging</topic><topic>Kidney Neoplasms - surgery</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Microwaves - therapeutic use</topic><topic>Postoperative Complications - diagnostic imaging</topic><topic>Radiology</topic><topic>Retrospective Studies</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wells, Shane A.</creatorcontrib><creatorcontrib>Wheeler, Karen M.</creatorcontrib><creatorcontrib>Mithqal, Ayman</creatorcontrib><creatorcontrib>Patel, Mehul S.</creatorcontrib><creatorcontrib>Brace, Christopher L.</creatorcontrib><creatorcontrib>Schenkman, Noah S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Abdominal imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wells, Shane A.</au><au>Wheeler, Karen M.</au><au>Mithqal, Ayman</au><au>Patel, Mehul S.</au><au>Brace, Christopher L.</au><au>Schenkman, Noah S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment</atitle><jtitle>Abdominal imaging</jtitle><stitle>Abdom Radiol</stitle><addtitle>Abdom Radiol (NY)</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>41</volume><issue>6</issue><spage>1203</spage><epage>1211</epage><pages>1203-1211</pages><issn>2366-004X</issn><eissn>2366-0058</eissn><abstract>Purpose
To update the oncologic outcomes and safety for microwave (MW) ablation of T1a (≤4.0 cm) and T1b (4.1–7.0 cm) renal cell carcinoma (RCC) with emphasis on tumor complexity and single session treatment.
Materials and Methods
Retrospective review of 29 consecutive patients (30 tumors) with localized (NOMO) RCC (23 T1a; 7 T1b) treated with percutaneous MW ablation between 3/2013 and 6/2014. Primary outcomes investigated were technical success, local tumor progression (LTP), and complications. Technical success was assessed with contrast-enhanced computed tomography (CECT) immediately after MW ablation. Presence of LTP was assessed with CECT or contrast-enhanced magnetic resonance at 6-month target intervals for the first two years and annually thereafter. Complications were categorized using the Clavien-Dindo classification system.
Results
Median tumor diameter was 2.8 cm [IQR 2.1–3.3] for T1a and 4.7 cm [IQR 4.1–5.7] for T1b tumors. Median RENAL nephrometry score was 7 [IQR 4–8] for T1a tumors and 9 [IQR 6.25–9.75] for T1b tumors. Technical success was achieved for 22 T1a (96%) and 7 T1b (100%) tumors. There were no LTP during a median imaging follow-up of 12.0 months [IQR 6–18] for the 23 patients (24 tumors) with greater than 6 months of follow-up. There were three Clavien-Dindo grade I–II complication (10%) and no Clavien-Dindo grade III–V complications (0%). All but two patients (93%) are alive without metastatic disease; two patients died after 12-month follow-up of causes unrelated to the MW ablation.
Conclusion
Percutaneous MW ablation appears to be a safe and effective treatment option for low, moderate, and highly complex T1a and T1b RCC in early follow-up.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>27167230</pmid><doi>10.1007/s00261-016-0776-x</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2366-004X |
| ispartof | Abdominal imaging, 2016-06, Vol.41 (6), p.1203-1211 |
| issn | 2366-004X 2366-0058 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1793905372 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Aged Biopsy Carcinoma, Renal Cell - diagnostic imaging Carcinoma, Renal Cell - surgery Catheter Ablation - methods Contrast Media Disease Progression Female Gastroenterology Hepatology Humans Imaging Kidney Neoplasms - diagnostic imaging Kidney Neoplasms - surgery Magnetic Resonance Imaging Male Medicine Medicine & Public Health Microwaves - therapeutic use Postoperative Complications - diagnostic imaging Radiology Retrospective Studies Tomography, X-Ray Computed Treatment Outcome |
| title | Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T06%3A34%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Percutaneous%20microwave%20ablation%20of%20T1a%20and%20T1b%20renal%20cell%20carcinoma:%20short-term%20efficacy%20and%20complications%20with%20emphasis%20on%20tumor%20complexity%20and%20single%20session%20treatment&rft.jtitle=Abdominal%20imaging&rft.au=Wells,%20Shane%20A.&rft.date=2016-06-01&rft.volume=41&rft.issue=6&rft.spage=1203&rft.epage=1211&rft.pages=1203-1211&rft.issn=2366-004X&rft.eissn=2366-0058&rft_id=info:doi/10.1007/s00261-016-0776-x&rft_dat=%3Cproquest_cross%3E4227644981%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1832216118&rft_id=info:pmid/27167230&rfr_iscdi=true |